Clinical Trial Update: Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

View source ↗

Summary

A clinical trial is evaluating the risk of myocarditis or cardiomyopathy in cancer patients receiving immune checkpoint inhibitor therapy. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiomyopathy
• Myocarditis

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Cardio-Oncology, Cardiomyopathy Due to Drug | Status: RECRUITING